Mitogenic signaling cascades in glial tumors

Gurpreet S Kapoor1, Donald M O'Rourke

  • 1Department of Neurosurgery, University of Pennsylvania School of Medicine, 36th and Hamilton Walk, Philadelphia, PA 19104, USA.

Neurosurgery
|May 24, 2003
PubMed

Insights

This review explores receptor tyrosine kinase signaling in glioma development. Understanding these pathways and their interaction with cell cycle regulators can lead to targeted therapies for brain tumors.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Gliomas are primary brain tumors originating from glial cells.
  • Histological classification is standard, but genetic alterations are increasingly important.
  • Genetic changes often involve receptor tyrosine kinase (RTK) pathways or cell cycle control.

Purpose of the Study:

  • To review the role of RTK signaling in gliomagenesis.
  • To emphasize the interplay between RTK signaling and cell cycle regulation.
  • To highlight the potential for targeted therapies based on molecular profiles.

Main Methods:

  • Literature review of gliomagenesis.
  • Analysis of genetic alterations in gliomas.
  • Focus on RTK and cell cycle pathway interactions.

Main Results:

  • RTK signaling pathways are frequently altered in gliomas.
  • Cooperative interactions exist between RTK signaling and cell cycle machinery.
  • Genetic insights complement histopathological diagnosis.

Conclusions:

  • Understanding molecular pathways is crucial for glioma treatment.
  • Targeted interventions can be developed for specific glioma subsets.
  • Molecular knowledge aids in designing rational adjuvant therapies for refractory gliomas.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...